RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation - Wikidata - wikimedia - TriplyDB

RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation

RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation

http://www.wikidata.org/entity/Q28482199

about

The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats The effect of chromium picolinate supplementation on the pancreas and macroangiopathy in type II diabetes mellitus rats.RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.FSP-1 Impairs the Function of Endothelium Leading to Failure of Arteriovenous Grafts in Diabetic Mice Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis.Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs.Hyperoside downregulates the receptor for advanced glycation end products (RAGE) and promotes proliferation in ECV304 cells via the c-Jun N-terminal kinases (JNK) pathway following stimulation by advanced glycation end-products in vitro.Catalpol ameliorates diabetic atherosclerosis in diabetic rabbits.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms Investigation of phosphoproteome in RAGE signaling.Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells.Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.Protein disulfide isomerase-mediated apoptosis and proliferation of vascular smooth muscle cells induced by mechanical stress and advanced glycosylation end products result in diabetic mouse vein graft atherosclerosis.Effects of candesartan cilexetil and amlodipine orotate on receptor for advanced glycation end products expression in the aortic wall of Otsuka Long-Evans Tokushima Fatty (OETFF) type 2 diabetic rats.The influence of glyoxalase 1 gene polymorphism on its expression at different stages of breast cancer in Egyptian women.Role of nifedipine and hydrochlorothiazide in MAPK activation and vascular smooth muscle cell proliferation and apoptosis.

P2860

Q33615012-84AEE41B-0C35-4076-83C2-C10FED516E75 Q33905136-AF53BA70-2DD4-40D9-A531-21C56655456E Q34008663-060858CD-D1E1-4719-BB22-11E8112F35DD Q35603308-8BCF7FB3-2144-4586-8C00-735C24E7FFAE Q35815734-C6611E87-39A7-471D-852E-31E41BC08520 Q36797594-C0581B83-310C-4269-9567-186546FFFB04 Q36996149-23F47051-F8CB-4B20-940E-5E839FAEC5CA Q37375512-57023077-984E-4A62-A51E-14EC0983B3D9 Q37393435-15A1E32D-CBE1-4EDD-B99A-50F3B3DDFE60 Q37636453-8A034D8F-387F-43CB-AD3C-6EC96EDA10BA Q38260264-3916BF6A-F077-48E3-9551-90346D0B3161 Q38811614-19A44F86-DED2-4C78-8977-01B609D71DC3 Q38831558-C3DD5A0C-F615-41EC-9646-5A00F31BC5A8 Q41082732-E116FFFC-A4E2-44CD-9649-AEE7FA98D2B2 Q46582498-E3E4D35F-634B-4171-933F-606CAFB81B0A Q49363984-AE2E48B2-1F81-44E9-96D6-26CF11A4FD59 Q51335172-27F87AAF-F373-455F-A260-2A098B28ADF6

P2860

RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation

http://www.wikidata.org/entity/Q28482199

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

RAGE mediates accelerated diab ...... via synergistic ERK activation

@ast

RAGE mediates accelerated diab ...... via synergistic ERK activation

@en

RAGE mediates accelerated diab ...... via synergistic ERK activation

@nl

type

label

RAGE mediates accelerated diab ...... via synergistic ERK activation

@ast

RAGE mediates accelerated diab ...... via synergistic ERK activation

@en

RAGE mediates accelerated diab ...... via synergistic ERK activation

@nl

prefLabel

RAGE mediates accelerated diab ...... via synergistic ERK activation

@ast

RAGE mediates accelerated diab ...... via synergistic ERK activation

@en

RAGE mediates accelerated diab ...... via synergistic ERK activation

@nl

P1433

Q28482199-CECC46E1-C199-44D5-9135-7916E1AEE991

P1476

Q28482199-BAE11870-802B-4611-8871-985F0126CE81

P2093

Q28482199-03250861-B1D3-4748-AC43-1B1A505DF745

Q28482199-0722A2C8-9062-4689-814B-624AC57557F3

Q28482199-1ED67046-9792-4D54-BC28-0805FC6C76A0

Q28482199-28C4DE9B-5727-4600-8BAC-955F8FECB5D0

Q28482199-46F11408-1558-46C5-A0D2-90EC8C379456

Q28482199-4C7214D4-F9D6-4641-AA60-55A0FEBAA96C

Q28482199-7B109AEF-B24B-4601-A138-819CA21D27CF

Q28482199-A25AC40E-87E5-46AB-A309-482A35FCFB3B

Q28482199-BF67D7C8-9A9E-409E-B593-7689AB73B131

Q28482199-BF808DBE-C5B2-41DE-BB03-114845CE9F2C

P2860

Q28482199-0149EC11-F7BC-45FC-B833-B8C33723CFF2

Q28482199-0A0E065E-FDAF-4A84-BECE-55E0C99EA6CF

Q28482199-0ABB1F19-1A5C-426E-9938-33F59F781495

Q28482199-0FD4E276-2D26-4D00-916C-17AD06C9FE47

Q28482199-19E44BA9-3202-440D-A6A9-95BD795B5E2E

Q28482199-1F7D0BE3-6539-4D8D-83D7-D4CCA11F4645

Q28482199-25695DDC-B6CB-464D-9653-D9545D3BD377

Q28482199-28DCAE5D-2952-46C8-96D5-CE8E935818B4

Q28482199-2A52EFAE-968B-445C-9749-984AA064550D

Q28482199-31D66952-A3D0-4684-8BDA-A67A81912947

P304

Q28482199-F8380964-0C93-4C05-85AF-A47C91169662

P31

Q28482199-3434C26C-8594-4D9A-A7B0-39F4D81468FF

P3181

Q28482199-3A95BE2D-54BF-4436-8CAD-B1978ED8AFA1

P356

Q28482199-39DB8687-5537-4E16-B4CA-D7F29BF684D9

P407

Q28482199-B7713E68-4100-4ED3-B98F-1CFD7B3C7C3B

P433

Q28482199-F6448533-9EDD-4730-AC1C-AF12288B94ED

P478

Q28482199-D6D0EB7D-682A-467F-A269-0E46230865A2

P577

Q28482199-9F8D9A7D-4CA1-4E87-B5AD-F15CF07E545F

P5875

Q28482199-B889F05D-3AD1-498C-BAD4-28D2135A8E9B

P698

Q28482199-8551B108-04CE-4478-99D3-658C8777616E

P921

Q28482199-AF55ABF6-5923-43B0-83AD-20849CFBEF7C

P932

Q28482199-3637D18F-4857-455D-9D13-3200F97BB556

P3181

P356

JOURNAL.PONE.0035016

P1433

P1476

RAGE mediates accelerated diab ...... via synergistic ERK activation

@en

P2093

Chaohong Li

http://www.w3.org/2001/XMLSchema#string

Chen Li

http://www.w3.org/2001/XMLSchema#string

Dadi Chen

http://www.w3.org/2001/XMLSchema#string

Fukang Xie

http://www.w3.org/2001/XMLSchema#string

Jingjing Wang

http://www.w3.org/2001/XMLSchema#string

Jintao Huang

http://www.w3.org/2001/XMLSchema#string

Liping Hu

http://www.w3.org/2001/XMLSchema#string

Min Zhang

http://www.w3.org/2001/XMLSchema#string

Qingbo Xu

http://www.w3.org/2001/XMLSchema#string

Shuying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice

Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes

Mechanical stress-initiated signal transductions in vascular smooth muscle cells.

Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society.

Advanced protein glycosylation in diabetes and aging.

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy.

Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.

P304

e35016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

843341

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0035016

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223978144

http://www.w3.org/2001/XMLSchema#string

P698

22496883

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3322163

http://www.w3.org/2001/XMLSchema#string